01 2Orion Corporation
02 4Cohance Lifesciences
03 2Strides Pharma Science
04 1Mankind Pharma
05 32care4
06 2AAIPharma Services Corp.
07 1ABRAXIS PHARM
08 7Abbott Laboratories
09 11Actavis Inc
10 2Amneal Pharmaceuticals
11 1Amphastar Pharmaceuticals
12 3Apotex Fermentation Inc.
13 1Aspiro Pharma
14 1Aurobindo Pharma Limited
15 4Avet Pharmaceuticals
16 7Azurity Pharma
17 1BEDFORD LABS
18 1BGP PHARMA ULC
19 2Caplin Point Laboratories Limited
20 3Chartwell Pharmaceuticals llc
21 2Epione Medicine Aps
22 2Exela Pharma Sciences, LLC.
23 4Farbe Firma
24 1Fresenius Kabi USA
25 1GD Searle LLC
26 1GLAND PHARMA LIMITED
27 3Glenmark Pharmaceuticals
28 2Hexal AG
29 7Hospira, Inc.
30 3IVAX Pharmaceuticals Inc
31 2Luitpold Pharmaceuticals, Inc.
32 2MARSAM PHARMS LLC
33 4MT ADAMS
34 1Macure Pharma
35 2Micro Labs Limited
36 2Mutual Pharmaceutical Company, Inc.
37 2Nephron Pharmaceuticals Corporation
38 2Nordic Prime Aps
39 2ORIFARM GROUP AS
40 9Pfizer Inc
41 1Pharmascience Inc.
42 4Pliva Hrvatska
43 1Pluviaendo
44 1Quad Pharma
45 8Rising Pharmaceuticals Inc
46 2SMITH & NEPHEW INC
47 2Sandoz B2B
48 1Smith & Kenner Pharmaceuticals
49 1Solo Pak
50 4Somerset Pharmaceuticals Inc
51 5Sun Pharmaceutical Industries Limited
52 14Viatris
53 2Warner Chilcott Company, LLC
54 6Zydus Lifesciences
55 1Zydus Pharmaceuticals
01 13CAPSULE, EXTENDED RELEASE;ORAL
02 1Capsule
03 3Extended-Release Tablet
04 10Film Coated Tablet
05 22INJECTABLE;INJECTION
06 1Injectable Solution
07 1Injectable; Injection
08 4Injection
09 1Injection/Infusion Solution
10 1LIQUID
11 1Modified Release Capsule
12 9Prolonged-Release Tablet
13 18SOLUTION;INTRAVENOUS
14 1SRC
15 1SRT
16 4Sustain Release Capsule
17 4TAB
18 2TABLET
19 3TABLET (EXTENDED-RELEASE)
20 29TABLET, EXTENDED RELEASE;ORAL
21 35TABLET;ORAL
22 2Tablet
01 1Allowed
02 7Authorized
03 66DISCN
04 1Deregistered
05 2Generic
06 4Originator
07 23Prescription
08 51RX
09 11Blank
01 2AA-VERAP
02 5CALAN
03 3CALAN SR
04 2COVERA-HS
05 4ISOPTIN
06 1ISOPTIN SR
07 6Isoptin Retard
08 1Isoptine L.P.
09 1MYLAN-VERAPAMIL SR
10 2Manidon
11 1Manidon Hta
12 1Manidon Hta Gradual-Release Tablets
13 2Manidon Retard
14 1PMS-VERAPAMIL SR
15 4Tarka
16 2Tarka 180/2
17 2Tarka 240/4
18 1VERAPAMIL HCL
19 96VERAPAMIL HYDROCHLORIDE
20 1VERAPAMIL HYDROCHLORIDE INJECTION USP
21 4VERELAN
22 3VERELAN PM
23 1Verahexal 240 Sr
24 1Veraloc
25 1Veraloc Retard
26 1Veramacor
27 1Verapamil Hydrochloride "2Care4"
28 1Verapamil "2Care4"
29 1Verapamil "Epione Medicine"
30 2Verapamil "Hexal"
31 2Verapamil "Nordic Prime"
32 10Blank
01 6Canada
02 17Denmark
03 9India
04 6South Africa
05 7Spain
06 1Sweden
07 1Switzerland
08 1Turkey
09 118USA
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Veraloc Retard
Dosage Form : Prolonged-Release Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 28-06-1985
Application Number : 28101171983
Regulatory Info : Prescription
Registration Country : Denmark
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 120MG
Packaging :
Approval Date : 1999-05-25
Application Number : 75072
Regulatory Info : RX
Registration Country : USA
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2022-06-15
Application Number : 214653
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Veraloc
Dosage Form : Tablet
Dosage Strength : 80mg
Packaging :
Approval Date : 01-04-1982
Application Number : 28101067881
Regulatory Info : Prescription
Registration Country : Denmark
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 180MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 240MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 240MG
Packaging :
Approval Date : 1999-05-25
Application Number : 75072
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/2ML (2.5MG/ML)
Packaging :
Approval Date : 1984-03-30
Application Number : 18925
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/4ML (2.5MG/ML)
Packaging :
Approval Date : 2018-04-05
Application Number : 18925
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 1984-03-30
Application Number : 19038
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1984-09-10
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1984-09-10
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-02-23
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-02-23
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 18485
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-03-08
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-03-08
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1987-11-23
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
